TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KARD

Kardigan, Inc.

Healthcare · Biotechnology

14.80$ +2.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Kardigan, Inc. (KARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 391 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KARD
Line item 2024 2025
64 391
50 345
49 109
– 335
– 23
147 641
8.3 38
– 3.1
3.9 8.0
-83 -250
-89 -281
89 60

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?